Patient No De novo tumor Liver disease Sex IMS Time from OLT to malignancy (months) Treatment Outcome Post-Tumor
Follow-Up
(months)
1 Esophagus ALD f CyA 57 surgery alive nf 122
2 Esophagus ALD m CyA 49 rt+ cht + palliation died nr 13
3 Esophagus ALD m CyA 84 surgery + rt + cht alive nf 83
4 Esophagus ALD m FK 66 palliation died nr 5
5 Esophagus ALD m CyA 45 palliation died nr 15
6 Neck ALD m CyA 146 surgery alive nf 18
7 Larynx ALD f CyA 6 surgery + rt died nr 139
8 Salivary gland  

ALD

m  

CyA

2  

surgery + rt

alive nf 132
9 Larynx HCV/HBV m CyA 98 palliation died nr 7
10 Tongue ALD m CyA 19 surgery died nr 5
11 Tongue ALD m FK 13 surgery + rt alive nf 99
12 Pharyngeal ALD f CyA 131 palliation died nr 1
13 Stomach ALD m CyA 49 surgery died nr 4
14 Stomach HBV m FK 77 surgery + rt + cht alive nf 39
15 Stomach ALD m FK 53 surgery died nr 1
16 Lung HCV/HBV m CyA 133 surgery died nr 3
17 Lung PLD m FK 13 rt+cht died nr 2
18 Lung PSC m FK 34 cht died nr 29
19 Lung ALD m FK 21 cht died nr 10
20 Colon HBV m CyA 159 surgery died nr 10
21 Colon PSC-HCV m CyA 133 surgery + cht alive nf 30
22 Melanoma ALD m CyA 97 surgery alive nf 20
23 Melanoma HCV/HBV f FK 15 surgery + ifn alive nf 71
24 Cervix ALD f CyA 84 surgery+rt alive nf 84
25 Cervix HCV f CyA 11 surgery died nr 16
26 Breast PBC f FK 13 surgery alive nf 94
27 Kaposi hbv-hdv m CyA 13 surgery died nr 54
28 Kaposi hbv m FK 36 surgery died nr 93
29 Kaposi hbv m FK 133 surgery alive nf 7
30 Kaposi SSC m CyA 56 surgery died nr 40
31 Kaposi ALD m CyA 5 reduction IMS alive wn 108
32 Kaposi hcv f FK 3 surgery alive nf 94
33 PTLD hbv m CyA 72 surgery cht died nr 64
34 PTLD PSC-hcv f CyA 66 surgery cht died nr 13
35 PTLD hcv m FK 36 cht alive nf 32
36 PTLD HCV-HBV m FK 58 cht+rt alive nf 44
37 PTLD HCV m FK 101 cht died nr 3
38 PTLD HBV m CyA 12 cht+rituximab alive nf 24
39 PTLD HCV f FK 106 cht alive nf 16
40 PTLD HCV m FK 80 palliation died nr 0
ALD: Alcoholic Liver Disease; PSC: Primary Sclerosing Cholangitis; PBC: Primary Biliary Cirrhosis; PLD: Polycystic Liver Disease; SSC: Secondary Sclerosing Cholangitis; nf: neoplsia free; nr: neoplasia related; wn: with neoplasia; cht: chemotherapy; rt: radiotherapy; IMS: Immunosuppression; PTLD: Post-Transplant Lymphoproliferative Disease
Table 2: Clinical characteristics of the 40 patients with de novo tumor.